NCT01612689已完成不适用
3-Dimensional Accelerometer Sub-Study for Patients Participating in the E-30 Study: Heart Rate Changes in Subjects With Epilepsy During an Epilepsy Monitoring Unit Admission
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
- 试验地点
- 2
- 主要终点
- Gather physiological data
研究概览
简要总结
This is a prospective, unblinded sub-study to the E-30 to gather physiological data.
详细描述
This sub-study to the E-30 is designed to collect vital signs, accelerometer and ECG data on subjects, and will consist of two phases. Phase 1 is designed to collect data in an Epilepsy Monitoring Unit (EMU) and Phase 2 is designed to collect data in an everyday (ambulatory) setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 6 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject be scheduled to participated in the E-30 parent study for a minimum of 48 hours
- •Subject has a clinical diagnosis of epilepsy based on a prior EMU visit
- •(Phase 1&2)
- •Subject is currently enrolled or previously participated in the E-30 study
- •Subject must be 6 years of age or older
- •(Sleep State: Optional)
- •Subject must be 12 years of age
- •Subject is currently enrolled in the E-30S sub-study and is willing to stay in a light controlled environment in the EMU for up to 120 hours
排除标准
- •(Phase 1&2)
- •Subjects with a medical condition that in the opinion of the investigator would affect his/her ability to participate in the sub-study.
- •Subject who has implanted defibrillator, pacemaker or Vagus Nerve Stimulation Therapy® (VNS) System
- •Subjects who are pregnant or lactating
- •Subjects with severe psychiatric disease that in the opinion of the investigator would prevent the subject's successful completion of the sub-study.
- •Subjects 6 to 16 years of age with moderate/severe learning difficulties or those who may be at risk of self-harm.
- •Subjects prescribed drugs specifically for a cardiac or autonomic disorder that in the investigator's opinion would affect heart rate response unless the patient has ictal tachycardia while taking said drugs. These include, but are not limited to, beta adrenergic antagonists ("beta blockers").
- •Subjects with cardiovascular arrhythmias or cardiac disease that would preclude the ability to detect intrinsic changes in heart rate due to activity, stress, or seizure. This would include but not be limited to chronic atrial fibrillation or chronotropic incompetence.
- •Subjects with a history of dependence on alcohol or narcotic drugs within the past 2 years as defined by DSM IV-R.
- •(Sleep State: Optional)
- •Subjects with a history if gastrointestinal disease (GI)or GI surgery
- •Subjects with a history of difficulty swallowing
- •Subjects with diabetes mellitus
- •Subjects with uncontrolled hypertension
- •Subjects with planned MRI during EMU stay
研究组 & 干预措施
Physiologic Data Collection
Experimental
干预措施: Accelerometer Device (Device)
结局指标
主要结局
Gather physiological data
时间窗: Up to 2 weeks
The purpose of this sub-study is to gather physiological data in consenting subjects who were previously enrolled in the "parent" E-30 study (NCT01202669).
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs)Cell CarcinomaNCT05623748Chang Gung Memorial Hospital160
已完成
不适用
A Novel Approach to Inpatient Pediatric Physical Activity Measurement - The 6th Vital SignPhysical ActivitySurgeryNCT03064529Ann & Robert H Lurie Children's Hospital of Chicago175
Unknown
不适用
Evaluation of the New Acceleromyograph TOF 3DAssessment of a New AcceleromyographNeuromuscular BlockNCT05005676Kreiskrankenhaus Dormagen50
Unknown
不适用
Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older AdultsCoronary Artery DiseaseHeart FailureNCT02635477American College of Cardiology150
已完成
不适用
Monitoring of Cardiac Function With 3-axis AccelerometersSurgery, Heart, Functional Disturbance as Result HeartNCT01926067Oslo University Hospital20